You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Aug. 27 2019 – Astellas today announced the appointments of a new Brand General Manager for new products in the company’s oncology franchise, and a new senior vice president to its Patient Centricity organization.
Phil Tennant joins as Brand General Manager, New Oncology Products
Phil Tennant will join the company as Brand General Manager for new products in the company’s oncology franchise. In this role, Tennant will be responsible for setting a unified global brand direction for new oncology products and leading the creation of marketing strategies for these products across priority markets. He will be located at Astellas’ U.S. office in Northbrook, Illinois, and will report directly to Yukio Matsui, Chief Commercial Officer.
“We are pleased that Phil has joined Astellas to lead global marketing strategy for our newest oncology treatments,” said Yukio Matsui, Chief Commercial Officer, Astellas. “Phil’s extensive commercial experience is uniquely suited to further enhance our approach to maximizing the value of new oncology products and continue the global growth of our oncology business with a strong focus on improving patients’ lives.”
Tennant joins Astellas from Bristol-Myers Squibb, where he most recently served as Head, Hematology Marketing, US Oncology. Throughout his 25-plus year career in the biopharmaceutical industry, Tennant has worked in multiple therapeutic areas across the globe, including Japan, US, Europe and Australia. He has successfully led businesses by building commercial capabilities, delivering brand strategies, and developing organizations across geographies. Tennant has also held leadership roles at AstraZeneca and Merck.
Tennant earned a Bachelor of Arts degree in Politics from the University of Warwick in the United Kingdom.
Dr. Anthony Yanni joins as Senior Vice President, Patient Centricity
Dr. Anthony Yanni will join the company as Senior Vice President, Patient Centricity. In this role, Dr. Yanni will have responsibility for leading the development and execution of Astellas’ global patient centricity strategy across all functions of the organization. He will be located at Astellas’ U.S. office in Northbrook, Illinois, and will report directly to Corporate Executive Vice President and Chief Strategy Officer Naoki Okamura.
“At Astellas, we strive every day to turn innovative science into value for patients,” said Okamura. “Anthony will help ensure the patient perspective advances our understanding of patient need, clinically meaningful benefit and medical value across the drug life cycle from early stage and into the marketplace. He is ideally suited to lead us as we continually strengthen the patient-centric work we have already started.”
Dr. Yanni was most recently Global Head, Patient Insights, Solutions and Outcomes for Sanofi Medical in Bridgewater, New Jersey. He is credited with creating one of the first-in-industry processes to integrate the patient and clinician perspective into research portfolio decision-making and has extensive experience in portfolio prioritization processes for research and early development. Previously, he held several leadership positions with Sanofi and served as Chief Medical Officer of a regional health system in Pennsylvania. His career also includes over 12 years of direct patient care in outpatient, inpatient and critical care medicine as a board-certified physician.
Dr. Yanni earned a Bachelor of Science in biology from the University of Scranton, a Master of Business Administration from the University of Massachusetts and his Medical Doctorate from Hahnemann University School of Medicine in Philadelphia, Penn.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.com/us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
Director, Culture & Patient Focus Communications, Corporate Affairs
ASTELLAS US LLC
1 Astellas Way, Northbrook, IL 60062
# # #
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.